echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Who says veterinarians can't take human drugs? He's in charge of a century-old pharmaceutical company with slugs and otters.

    Who says veterinarians can't take human drugs? He's in charge of a century-old pharmaceutical company with slugs and otters.

    • Last Update: 2020-06-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Veterinarians and human medicine can still wipe out sparks34 years ago, Li Zhenguo's job was that of a dairy farm technician, and 34 years later, Li Zhenguo, chairman of Jiuzhitang, which has a history of 370 years, was no longer the yellow-haired boy who had been dealing with test tubes and beakers all dayfrom the ordinary grass-roots workers, after hard research and struggle, research and development of ten years of successful market "golden varieties" productdredging injection inventor, the last "small swallow big" successfully borrowed the shell Jiuzhitang listing, become the chairman, his first half of life, can only be described with two words legendaryLi Zhenguo,,from dairy farm technician to researcher,1960 born Li Zhenguo, graduated from the Northeast Agricultural College (now "Northeastern Agricultural University"), specializing in animal husbandry and animal medicine, also known as "veterinarians"His first job was as a dairy technicianIn 1986, 32-year-old Li Zhenguo was sent to Shenzhen to set up a biological research institute because of his excellent research skillsbegan by selecting a research project that was at the time a national problem: the development of extracts from dillons and otters as drugs for cardiovascular diseases, and his goal was to extract the extracts into the body directly into the bodyThis was a matter of skill level at the timeBecause it was impossible to extract and overcome protein allergies at the time, every expert he consulted saw as "whimsical", plus a veterinary-born Li Zhenguo, who was not optimistic about the project at the timebut it is precisely because of the non-Koban origin, so that Li Zhenguo on the pharmaceutical industry's many authorities have always had a slight lysis of the psychology, has not given up their own ideasHe felt that scientific research is to try many times, failed, start again, this is the normal rhythm, very boring, but also very enjoyable1986 to 1995, exactly ten years, ten years of extraction technology has also made rapid progress in development, Li Zhenguo succeeded, he initially developed a "blood-dredging injection", into the clinical stage, to fill the domestic gap1995, with the support of friends, Li Zhenguo in the form of technology shares, with the Peony River Tieling Village (Huaxing Enterprise Corporation) to form a friendly pharmaceutical factory, in 2000 enterprise restructuring, Youbo Pharmaceuticals completed the restructuring of township enterprises to private enterprises, Li Zhenguo 100% holding, officially began the road from businessgrafted the century-old old nine Zhitang listing legend 2000, dredging injection products officially listed, entered the market on the first year to obtain more than 200,000 profits of good results, in 2005 product sales are more than 10 million, revenue reached the level of 100 million In order to further optimize the product structure, AIA Pharmaceuticals in innovative research and development at the same time, began to acquire a number of pharmaceutical companies In 2003, it acquired Peony River Red Star Pharmaceutical Factory and became the largest shareholder of Heilongjiang Dillon Pharmaceuticals in 2011 since 2011, Mr Li has wanted to put the company on the market He felt that a drug can not drive the whole enterprise development for a long time, must be innovative development, and constantly develop new drugs, which requires funding 2015, a chance, someone to Li Zhenguo introduced the nine-chi-tang shell listing of the road, he felt his chance to come Jiuzhitang and the majority shareholder Chung Jin are in contact with Li Zhenguo at the same time was also reported in contact with Gadobao, China Resources and other institutions Finally, Jiuzhitang valued li Zhenguoyou Bo Pharmaceuticals' Chinese medicine enterprise identity, less than two months quickly reached an agreement May 25, 2015, the suspension of the suspension of four months of Jiuzhitang issued a restructuring plan, Li Zhenguo with friends and the pharmaceutical industry to realize the listing wish The shell scheme is divided into two parts, fixed to increase the injection of assets and large-amount equity transfer, the two are mutually premised, at the same time effective The underlying asset is a 100% stake in Uber Pharmaceuticals Li Zhenguo holds 320 million shares of Jiuzhitang, accounting for 42.33 percent, and will replace Chen Jinxia of the Chung Jin System as the actual controller of the listed company 2016, the new Jiuzhitang realized operating income of 2.67 billion yuan and net profit of 612 million yuan At the same time, revenue growth was 14.54 percent, 64.77 percent and 40.5 percent year-on-year, respectively, from the first three quarters of 2017 capital and innovation, 100 years old all-speed sailing
    as a scientific research origin of Li Zhenguo, has always believed that innovation is the first productivity of enterprise development 2017, Jiuzhitang, run by Li Zhenguo, is developing the REMD-477 molecule, which, if successfully developed, will be the world's first new antibody drug for diabetes 2018, Jiuzhitang has set its sights on the international frontier in the field of biological cells, as the United States St emedica company stem cell technology in China's sole undertaker, is committed to building the domestic stem cell drug industry standards November 2019, the application for a clinical trial of a new stem cell drug in Jiuzhitang was accepted by the National Drug Review Center Jiuzhitang said that in the future, the company will increase investment in research and development, and actively adjust the product structure, to promote the value of Chinese medicine in disease treatment, prevention and rehabilitation, health care Jiuzhitang and Youbo Pharmaceuticals can achieve today's achievements, the helm li Zhenguo can be said to be a credit From veterinarians to research and development of human medicine, by virtue of scientific research products to advance the business philosophy, 34 years later, Li Zhenguo, has completed from the technician to the chairman of the metamorphosis, life will have unlimited possibilities, practical people work hard, and Jun!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.